Venetoclax

Venetoclax
Product Description

We offer an integral secure solution as your startegic partner of Venetoclax. 
Venetoclax (CAS 1257044-40-8) is a targeted therapy drug used to treat chronic lymphocytic leukaemia (CLL),  manufactured in our unique European GMP manufacturing plant located in Barcelona, Spain. Venetoclax   is available with full regulatory support, including EU DMF/ GMP certificate. Our clients are the main pharmaceutical companies in the world. More than 90% of our production is sold in the worldwide pharmaceutcial market. 

Lebsa

  • Country/Region:
    Spain
  • On CPHI since:
    2019
  • Certificates:
    3
  • Employees:
    25 - 49
Company types
Pharmaceutical company
Primary activities
API Producer
Specifications
  • CAS Registry Number
    1257044-40-8
  • Supplied from
    Spain

Lebsa

  • Country/Region:
    Spain
  • On CPHI since:
    2019
  • Certificates:
    3
  • Employees:
    25 - 49
Company types
Pharmaceutical company
Primary activities
API Producer

More Products from Lebsa (2)

  • Letermovir

    Product Letermovir

    Letermovir (CAS-RN 917389-32-3) is an antiviral agent approved in 2017 by the US FDA to be used in prophylaxis of cytomegalovirus (CMV) infection and disease in adult CMV-seropositive recipients of an allogeneic hematopoietic stem cell transplant (HSCT). Designated an orphan drug by FDA for prevention of C...
  • Octenidine dihydrochloride

    Product Octenidine dihydrochloride

    Octenidine dihydrochloride (CAS 70775-75-6) is an antiseptic  manufactured in our unique European GMP manufacturing plant located in Barcelona, Spain. Octenidine dihydrochloride (CAS 70775-75-6)  is available with full regulatory support, inc...

Lebsa resources (1)